Rheumatoid arthritis in a mouse?
作者信息
Firestein Gary S
出版信息
Nat Clin Pract Rheumatol. 2009 Jan;5(1):1. doi: 10.1038/ncprheum0973.
Abstract
摘要
相似文献
1
Rheumatoid arthritis in a mouse?小鼠患类风湿性关节炎？
Nat Clin Pract Rheumatol. 2009 Jan;5(1):1. doi: 10.1038/ncprheum0973.
2
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.动物模型在类风湿关节炎潜在治疗药物鉴定中的应用
Ann Rheum Dis. 2008 Nov;67(11):1505-15. doi: 10.1136/ard.2007.076430. Epub 2007 Nov 29.
3
[SCID-HuRAg mouse].
Nihon Rinsho. 2005 Jan;63 Suppl 1:59-67.
4
5
Animal models of rheumatoid arthritis.类风湿关节炎的动物模型。
Eur J Immunol. 2009 Aug;39(8):2040-4. doi: 10.1002/eji.200939578.
6
Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis.抗蛋白水解 uPA 抗体在类风湿关节炎中的鉴定和临床前开发。
J Mol Med (Berl). 2020 Apr;98(4):585-593. doi: 10.1007/s00109-020-01889-9. Epub 2020 Feb 27.
7
In Vivo Models of Rheumatoid Arthritis.类风湿关节炎的体内模型
Methods Mol Biol. 2019;1914:269-280. doi: 10.1007/978-1-4939-8997-3_14.
8
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis.三种不同类风湿关节炎动物模型中 MMP-13 高选择性抑制剂的口服给药效果。
Ann Rheum Dis. 2010 May;69(5):898-902. doi: 10.1136/ard.2008.106021. Epub 2009 Jun 3.
9
Adjuvant arthritis.
Arzneimittelforschung. 1976;26(10):1860-6.
10
[Evaluation of immunomodulators in animal experimental models of rheumatoid arthritis].
Ryumachi. 1988 Dec;28(6):450-2.
引用本文的文献
1
Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis.免疫调节微粒通过表观遗传修饰 T 细胞并全身性改善自身免疫性关节炎。
Adv Sci (Weinh). 2023 Apr;10(11):e2202720. doi: 10.1002/advs.202202720. Epub 2023 Mar 8.
2
Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis.催乳素和血管抑制素在炎性关节炎中的双重作用
Front Endocrinol (Lausanne). 2022 Jun 2;13:905756. doi: 10.3389/fendo.2022.905756. eCollection 2022.
3
Therapeutic Effects of Hypoxic and Pro-Inflammatory Priming of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Inflammatory Arthritis.缺氧和促炎预处理的间充质干细胞衍生细胞外囊泡在炎症性关节炎中的治疗作用。
Int J Mol Sci. 2021 Dec 23;23(1):126. doi: 10.3390/ijms23010126.
4
Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility to Physiological Proximity.类风湿关节炎的体外建模：从实验可行性到生理相似性。
Int J Mol Sci. 2020 Oct 25;21(21):7916. doi: 10.3390/ijms21217916.
5
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis.PTPN2 在实验性自身免疫性关节炎中连接结肠和关节炎症。
JCI Insight. 2020 Oct 15;5(20):141868. doi: 10.1172/jci.insight.141868.
6
Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal.靶向滑膜细胞的治疗与 TNF 抑制在关节炎逆转中协同作用。
Sci Adv. 2020 Jun 26;6(26):eaba4353. doi: 10.1126/sciadv.aba4353. eCollection 2020 Jun.
7
Development of macromolecular prodrug for rheumatoid arthritis.类风湿性关节炎的大分子前药的开发。
Adv Drug Deliv Rev. 2012 Sep;64(12):1205-19. doi: 10.1016/j.addr.2012.03.006. Epub 2012 Mar 10.
8
c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.c-Fms 介导的单核细胞系细胞的分化和启动在自身免疫性关节炎中起核心作用。
Arthritis Res Ther. 2010;12(1):R32. doi: 10.1186/ar2940. Epub 2010 Feb 24.
9
"Go upstream, young man": lessons learned from the p38 saga.“溯流而上，年轻人”：p38 传奇中的经验教训。
Ann Rheum Dis. 2010 Jan;69 Suppl 1(Suppl 1):i77-82. doi: 10.1136/ard.2009.119479.
10
The as-yet unfulfilled promise of p38 MAPK inhibitors.p38丝裂原活化蛋白激酶抑制剂尚未实现的前景。
Nat Rev Rheumatol. 2009 Sep;5(9):475-7. doi: 10.1038/nrrheum.2009.171.
Zotero 插件